Pranab Chatterjee MD, PhD
banner
pranab.stopamr.org
Pranab Chatterjee MD, PhD
@pranab.stopamr.org
Skeptic Oslerphile. PhD @johnshopkinssph.bsky.social #OneHealth #AMR #Zoonoses #InfectiousDiseases #Vaccines #Epidemiology #ClinicalTrials #IDSky + @stopamr.org: Building sustainable, healthy, AMR-resilient future. Also, @bhavnaseth.bsky.social's #1fan!
Also, the EIS Officer who investigated the diphtheria outbreak was Dr. Reimert Thorolf Ravenholt. A USAID legend, I’ve always wondered how Harry Potteresque his name is.
August 29, 2025 at 5:18 PM
And I’m left wondering about how much has remained unchanged in the decades since these landmark investigations happened.
August 29, 2025 at 5:16 PM
Thanks, doc!
August 27, 2025 at 11:32 AM
Thank you so much Dr. Pai! Still feels unreal. :-)
August 27, 2025 at 2:08 AM
Thank you! I still can’t believe it. Feels unreal.
August 27, 2025 at 2:00 AM
Bats are viral superheroes with fascinating immune systems.

Bats can host deadly viruses like Ebola, Nipah, and coronaviruses without getting sick. Their secret? A constantly “switched on” antiviral response and a finely tuned immune system that avoids the inflammation seen in other mammals.
June 23, 2025 at 4:04 AM
21/
TL;DR:
✅ Covid boosters: now targeted
✅ RCTs required for low-risk groups
✅ Trust in vaccines needs rebuilding
✅ FDA finally walking the evidence-based walk
Let’s hope it’s the beginning of a more measured era.
📄 @nejm.org article: www.nejm.org/doi/full/10....
#Covid19 #Vaccine #PublicHealth
An Evidence-Based Approach to Covid-19 Vaccination | NEJM
This article from the FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and announces the adoption of an evidence-based approach to such recommendations.
www.nejm.org
May 21, 2025 at 4:08 PM
20/
Parallel to trials, we must invest in restoring vaccine confidence: clear risk communication, community outreach, and rebuilding trust in public health, especially in communities hit hardest by Covid and misinformation.
#VaccineEquity #PublicHealth
May 21, 2025 at 4:07 PM
19/
As the FDA shifts to evidence-based booster approvals, we must urgently launch RCTs per FDA guidance:
✅ include 50–64 yr-olds
✅ allow prior Covid infection
✅ follow ≥6 months, and
✅ measure real-world outcomes (symptomatic illness, hospitalization, death).

#Covid19 #Vaccines #RCT #FDA
May 21, 2025 at 4:07 PM